JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)
CNY 9.85
(0.92%)
CNY 9.85
(0.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.22 Billion | 2.02 Billion | 1.77 Billion | 1.87 Billion | 2.1 Billion | 1.7 Billion |
| Cost of Revenue | 1.71 Billion | 1.44 Billion | 1.26 Billion | 1.29 Billion | 1.48 Billion | 1.09 Billion |
| Gross Profit | 506.67 Million | 579.66 Million | 511.91 Million | 575.31 Million | 624.56 Million | 603.45 Million |
| Operating Expenses | 614.32 Million | 595.3 Million | 533.7 Million | 605.34 Million | 627.77 Million | 639.73 Million |
| Selling, General and Administrative Expenses | 501.29 Million | 487.66 Million | 445.06 Million | 503.03 Million | 521.48 Million | 482.57 Million |
| Research and Development Expenses | 44.89 Million | 28.55 Million | 21.09 Million | 37.47 Million | 13.6 Million | 51.02 Million |
| Other Expenses | 48.73 Million | 79.07 Million | 67.54 Million | 64.83 Million | 92.69 Million | -32.5 Million |
| Cost and Expenses | 2.31 Billion | 2.04 Billion | 1.79 Billion | 1.9 Billion | 2.11 Billion | 1.73 Billion |
| Operating Income | -32.57 Million | -583.08 Thousand | 578.76 Thousand | -32.96 Million | 143.99 Million | -190.44 Million |
| Interest Expense | 76.34 Million | 74.59 Million | 64.67 Million | 64.41 Million | 52.02 Million | 39.11 Million |
| Income Tax Expense | 3.26 Million | 2.82 Million | 18.6 Million | 3.47 Million | 15.52 Million | 59.38 Million |
| Earnings before Tax | -77.03 Million | -75.4 Million | 39.24 Million | -504.12 Million | 77.28 Million | -222.94 Million |
| Net Income | -71.94 Million | -78.23 Million | 22.71 Million | -507.59 Million | 64.53 Million | -285.56 Million |
| Earnings Per Share Basic | -0.10 | -0.11 | 0.03 | -0.72 | 0.09 | -0.40 |
| Earnings Per Share Diluted | -0.10 | -0.11 | 0.03 | -0.72 | 0.09 | -0.40 |
| Weighted Average Shares Outstanding | 719.45 Million | 712.32 Million | 704.55 Million | 704.55 Million | 717.04 Million | 713.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 719.45 Million | 712.32 Million | 704.55 Million | 704.55 Million | 717.04 Million | 713.92 Million |
| Gross Margin | 0.23 | 0.29 | 0.29 | 0.31 | 0.30 | 0.35 |
| EBIT Margin | 0.02 | 0.02 | 0.03 | 0.03 | 0.11 | 0.16 |
| Profit Margin | -0.03 | -0.04 | 0.01 | -0.27 | 0.03 | -0.17 |
| EBITDA | 51.04 Million | 48.97 Million | 146.55 Million | -352.06 Million | 214.15 Million | -96.06 Million |
| Earnings Before Tax Margin | -0.01 | -0.00 | 0.00 | -0.02 | 0.07 | -0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 440.79 Million | 497.43 Million | 703.37 Million | 732.97 Million | 2.22 Billion | 402.71 Million |
| Cost of Revenue | 223.51 Million | 302.19 Million | 556.25 Million | 625.13 Million | 1.71 Billion | 283.95 Million |
| Gross Profit | 217.27 Million | 195.23 Million | 147.11 Million | 107.83 Million | 506.67 Million | 118.76 Million |
| Operating Expenses | 174.79 Million | 163.99 Million | 117.53 Million | 174.94 Million | 539.25 Million | 118.54 Million |
| Selling, General and Administrative Expenses | 232.07 Million | 154.67 Million | 112.15 Million | 162.48 Million | - | 137.9 Million |
| Research and Development Expenses | 10.79 Million | 9.28 Million | 10.19 Million | 10.92 Million | - | 10.69 Million |
| Other Expenses | -68.06 Million | -44.03 Thousand | -39.34 Thousand | -1.53 Million | -1.35 Million | -215.85 Thousand |
| Cost and Expenses | 398.31 Million | 466.19 Million | 673.78 Million | 800.08 Million | 2.25 Billion | 402.49 Million |
| Operating Income | 23.28 Million | 31.24 Million | 5.31 Million | -67.11 Million | -32.57 Million | -14.9 Million |
| Interest Expense | 17.52 Million | 18.82 Million | 22.79 Million | 19.03 Million | 76.34 Million | 22.31 Million |
| Income Tax Expense | 115.42 Thousand | 230.47 Thousand | 602.77 Thousand | 277.12 Thousand | 3.26 Million | 1.75 Million |
| Earnings before Tax | 22.69 Million | 20.51 Million | 5.27 Million | -76.69 Million | -77.03 Million | -15.11 Million |
| Net Income | 20.62 Million | 19.39 Million | 5.05 Million | -82.89 Million | -71.94 Million | -16.44 Million |
| Earnings Per Share Basic | 0.03 | 0.03 | 0.01 | -0.12 | - | -0.02 |
| Earnings Per Share Diluted | 0.03 | 0.03 | 0.01 | -0.12 | - | -0.02 |
| Weighted Average Shares Outstanding | 711.24 Million | 710.79 Million | 722.72 Million | 712.28 Million | 712.28 Million | 712.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 711.24 Million | 710.79 Million | 722.72 Million | 712.28 Million | 712.28 Million | 712.28 Million |
| Gross Margin | 0.49 | 0.39 | 0.21 | 0.15 | 0.23 | 0.29 |
| EBIT Margin | 0.09 | 0.09 | 0.04 | -0.08 | - | 0.02 |
| Profit Margin | 0.05 | 0.04 | 0.01 | -0.11 | -0.03 | -0.04 |
| EBITDA | 40.21 Million | 44.11 Million | 29.3 Million | -55.14 Million | - | 8.19 Million |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.01 | -0.09 | -0.01 | -0.04 |
AT1
8155
8904
HRI
AITUF
248070